Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N9PC | ISIN: CNE100003FF7 | Ticker-Symbol: 8SJ
Frankfurt
27.06.25 | 09:59
2,200 Euro
-1,79 % -0,040
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI JUNSHI BIOSCIENCES CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI JUNSHI BIOSCIENCES CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,1802,36019:03

Aktuelle News zur SHANGHAI JUNSHI BIOSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.06.JUNSHI BIO (01877): POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING-
20.06.JUNSHI BIO (01877): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* ANNOUNCEMENT ON COMPLETION OF PLACING OF NEW H SHARES UNDER ...2
20.06.JUNSHI BIO (01877): COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE-
SHANGHAI JUNSHI BIOSCIENCES Aktie jetzt für 0€ handeln
20.06.JUNSHI BIO (01877): NEXT DAY DISCLOSURE RETURN1
19.06.JUNSHI BIO (01877): CHANGE OF BOOK CLOSURE PERIOD AND RECORD DATE-
13.06.JUNSHI BIO Places Shrs at 11.5% Discount to Raise Net HKD1.03B1
13.06.JUNSHI BIO (01877): PLACING OF NEW H SHARES UNDER GENERAL MANDATE1
11.06.JUNSHI BIO (01877): VOLUNTARY ANNOUNCEMENT - JT118 RECEIVED THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION2
05.06.JUNSHI BIO (01877): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* INDICATIVE ANNOUNCEMENT ON THE CHANGE IN EQUITY OF THE SHAREHOLDERS ...1
29.05.JUNSHI BIO (01877): FORM OF PROXY FOR THE 2024 ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 20 JUNE 20253
29.05.JUNSHI BIO (01877): 2024 ANNUAL REPORTS AND ACCOUNTS 2024 PROFIT DISTRIBUTION PLAN CREDIT LINES FROM FINANCIAL INSTITUTION(S) FOR 2025 DIRECTORS' AND ...-
29.05.JUNSHI BIO (01877): NOTICE OF THE 2024 ANNUAL GENERAL MEETING1
29.05.JUNSHI BIO (01877): CLOSURE OF REGISTER OF MEMBERS OF H SHARES1
29.05.JUNSHI BIO (01877): ANNOUNCEMENT - ADJUSTMENTS TO THE USE OF PROCEEDS FROM THE 2022 ISSUANCE OF A SHARES-
27.05.Junshi Biosciences Announces Ongericimab's sNDA Approval in China334SHANGHAI, May 27, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the...
► Artikel lesen
27.05.JUNSHI BIO (01877): VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE SUPPLEMENTAL NEW DRUG APPLICATION FOR ONGERICIMAB INJECTION3
16.05.JPMorgan raises Junshi Biosciences rating to neutral2
25.04.JUNSHI BIO (01877): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* 2025 FIRST QUARTERLY REPORT3
25.04.JUNSHI BIO (01877): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* ANNOUNCEMENT ON THE PARTICIPATION IN THE 2024 ANNUAL RESULTS ...-
25.04.JUNSHI BIO (01877): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* ANNOUNCEMENT ON APPOINTMENT OF SECURITIES AFFAIRS REPRESENTATIVE1
Weiter >>
61 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1